Crossmark

Pharmacologic treatment with CPI-613 and PS48 decreases mitochondrial membrane potential and increases quantity of autolysosomes in porcine fibroblasts

Crossref DOI link: https://doi.org/10.1038/s41598-019-45850-4

Published Online: 2019-07-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mordhorst, Bethany R.

Kerns, Karl C. https://orcid.org/0000-0001-7425-0131
Schauflinger, Martin

Zigo, Michal https://orcid.org/0000-0002-2964-5940
Murphy, Stephanie L.

Ross, Renee M.

Wells, Kevin D.

Green, Jonathan A.

Sutovsky, Peter

Prather, Randall S. https://orcid.org/0000-0002-6012-4035
Funding

Funding for this research was provided by:

University of Missouri Life Science Fellowship.

United States Department of Agriculture | National Institute of Food and Agriculture (2017-67011-26023, 2015-67015-23231)

Foundation for the National Institutes of Health (R01HD080636, R01HD080636, R01HD080636)
License Information

Text and Data Mining valid from 2019-07-01

Version of Record valid from 2019-07-01
More Information

Article History

Received: 5 June 2018

Accepted: 14 June 2019

First Online: 1 July 2019

Competing Interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below